BioVie Presents New Biomarker Data from the ADDRESS-LC Trial of Bezisterim in Long COVID at the NIH RECOVER-TLC Third Annual Workshop

Stock Information for BioVie Inc.

Loading

Please wait while we load your information from QuoteMedia.